<?xml version='1.0' encoding='utf-8'?>
<document id="27430348"><sentence text="Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review."><entity charOffset="55-66" id="DDI-PubMed.27430348.s1.e0" text="fluconazole" /><entity charOffset="90-102" id="DDI-PubMed.27430348.s1.e1" text="atorvastatin" /><pair ddi="false" e1="DDI-PubMed.27430348.s1.e0" e2="DDI-PubMed.27430348.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27430348.s1.e0" e2="DDI-PubMed.27430348.s1.e1" /></sentence><sentence text="Rhabdomyolysis is a severe potential adverse drug reaction of statin therapy" /><sentence text=" We report a case of rhabdomyolysis due to drug-drug interaction (DDI) between atorvastatin and fluconazole and review the literature"><entity charOffset="79-91" id="DDI-PubMed.27430348.s3.e0" text="atorvastatin" /><entity charOffset="96-107" id="DDI-PubMed.27430348.s3.e1" text="fluconazole" /><pair ddi="false" e1="DDI-PubMed.27430348.s3.e0" e2="DDI-PubMed.27430348.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27430348.s3.e0" e2="DDI-PubMed.27430348.s3.e1" /></sentence><sentence text="" /><sentence text="A 70-year-old woman received atorvastatin for hyperlipidaemia without any problem for 4 years"><entity charOffset="29-41" id="DDI-PubMed.27430348.s5.e0" text="atorvastatin" /></sentence><sentence text=" When intravenous fluconazole was added for treating a fungal infection, rhabdomyolysis developed 2 weeks later"><entity charOffset="18-29" id="DDI-PubMed.27430348.s6.e0" text="fluconazole" /></sentence><sentence text=" Removal of atorvastatin led to the resolution of her rhabdomyolysis" /><sentence text="" /><sentence text="Our case demonstrates that in some subjects even a moderate CYP3A4 inhibitor such as fluconazole may lead to rhabdomyolysis in subjects receiving a statin"><entity charOffset="85-96" id="DDI-PubMed.27430348.s9.e0" text="fluconazole" /></sentence><sentence text="" /></document>